NANNING - In a high-tech hall at Guangxi Medical University in South China, a digital avatar came to life, speaking fluent Vietnamese to a room full of delegates from across Southeast Asia.

The scene unfolded at a ceremony on March 16, marking the official launch of the Guangxi Medical Artificial Intelligence Research Institute, the latest milestone in China's regional "AI + Healthcare" strategy.

Positioned as a specialized platform for China-ASEAN medical intelligence sharing, the institute was officially launched in Nanning, the capital of Guangxi Zhuang autonomous region. Its debut reflects the rising importance of regional hubs in China's broader AI strategy, aiming to export localized and cost-effective healthcare solutions to neighboring countries.

Guangxi, the only Chinese provincial-level region sharing both land and sea borders with ASEAN, leverages a "shared clinical profile." From hereditary blood disorders like thalassemia to tropical infectious diseases, the medical challenges in Guangxi closely mirror those faced across Southeast Asia, from Hanoi to Bangkok.

ALSO READ: Building AI bridges across regions

"Given our unique advantage of possessing a massive volume of characteristic clinical data, the institute will serve as a strategic hub," said Li Lang, vice-president of Guangxi Medical University.

"We import top-tier algorithms from China's tech hubs like Beijing and Shanghai, train them on our unique disease profiles, and refine them with ASEAN-specific data, so they truly accommodate local needs," Li added.

The launch drew a crowd of high-profile regional stakeholders, including Singapore's Agency for Science, Technology and Research (A*STAR) and Vietnam's Hue Central Hospital, alongside sectoral heavyweights such as Beijing Yidu Technology Holdings Co, Ltd, and Shanghai SenseTime Shancui Healthcare Technology Co, Ltd.

These projects represent the vanguard of the region's AI development strategy, in which high-end algorithms from China's tech capitals are retooled for the specific linguistic and pathological makeup of ASEAN, according to Li.

At the heart of this portfolio is Urology's Talk, described as the world's first interactive medical AI specializing in urology and supporting multiple ASEAN languages.

ALSO READ: China's TCM sector undergoing tech-driven transition

Unlike general-purpose chatbots, Urology's Talk is trained on specialized medical corpora to navigate the "last kilometer," enabling the seamless integration of clinical data into cross-border medical consultations, explained Cheng Jiwen, vice-president of the First Affiliated Hospital of Guangxi Medical University and one of the minds behind the platform's development.

"Telemedicine often falls short not because of the tech, but because of linguistic barriers," said Cheng. "We are bridging the clinical gap for minority dialects that global models often ignore. It allows for high-fidelity care between a specialist here in Nanning and a patient in rural Vietnam without the frictions of a human translator."

The system currently supports Mandarin, English and Vietnamese, with Thai, Burmese and Khmer modules in the pipeline.

Cheng emphasized the importance of building a rich local-language corpus, as many patients do not use "textbook" terminology. "In Vietnam and Cambodia, the same chest pain might be described with everyday phrases that a standard model simply doesn't recognize," Cheng said.

Beyond standard clinical protocols, efforts have also been made to modernize China's traditional healing methods by digitizing ancient practices to meet growing regional demand for more integrated healthcare.

READ MORE: Growing recognition of Chinese medical devices

Led by Huang Feng, a cardiovascular specialist at the Guangxi hospital, the AI Traditional Chinese Medicine (TCM) Constitution Identification Device digitizes the four traditional diagnostic methods -- watch, hear, ask and touch to feel the pulse -- via computer vision and big data.

While linguistic bridges and traditional medicine may broaden the institute's reach, its most clinically significant breakthrough to date targets a lethal genetic disease shared across the "Thalassemia Belt" of Southeast Asia.

The tool, aptly named Iron Detective, addresses a critical bottleneck in a region that houses one of the world's highest rates of thalassemia.

According to its developers, the AI-powered device helps assess iron overload in patients with hereditary blood disorders, a task vital to long-term survival.

Built on a repository of over 5,000 cases from China, Vietnam and Laos, the system automates MRI scan analysis, a process that is normally arduous and prone to human error.

Developed by Peng Peng, a radiologist at First Affiliated Hospital of Guangxi Medical University, it represents the largest single-hospital dataset of its kind globally.

"By slashing diagnostic costs by roughly two-thirds compared to other proprietary software, the tool has already been recognized in 52 hospitals in China and is being deployed via remote diagnostic links to community-level medical institutions," Peng said.

"AI is particularly powerful for grassroots healthcare in developing countries," said Li. "Our systems already perform at the level of a senior attending physician with seven or eight years of experience."

According to Zeng Zhiyu, president of Guangxi Medical University, the institute will operate under a clear framework, conducting research and development in collaboration with ASEAN partners to identify specific regional needs, refining solutions through Guangxi's clinical infrastructure, and then scaling them up across the region.

Liu Yong, with A*STAR, noted that Federated Learning -- a machine learning technique that enables collaborative model training without raw data leaving the premises -- was jointly developed with the First Affiliated Hospital of Guangxi Medical University.

Liu said A*STAR is seeking substantive cooperation with the hospital to leverage high-quality medical data and real-world scenarios while strictly safeguarding patient privacy.

Zeng underscored that Guangxi is evolving from a gateway for physical trade into an intellectual hub for regional digital healthcare.

"We are no longer just sharing medical talents; we are sharing healthcare intelligence for the two billion people in our shared neighborhood, facilitating high-end diagnostics viable for developing markets," Zeng said.